Predicting Remission at 6 Months in Early Rheumatoid Arthritis Treated with Conventional Synthetic Dmards

被引：0
|
作者：
Wiese, Michael D. [1 ]
Metcalf, Robert [2 ]
Wechalekar, Mihir D. [3 ]
Spargo, Llew [2 ]
McWilliams, Leah [4 ]
James, Michael [4 ,5 ]
Hill, Catherine [6 ]
Proudman, Susanna [7 ]
机构：
[1] Univ South Australia, Sch Pharm & Med Sci, Adelaide, SA, Australia
[2] Royal Adelaide Hosp, Rheumatol Unit, Adelaide, SA, Australia
[3] Royal Adelaide Hosp, Adelaide, SA, Australia
[4] Royal Adelaide Hosp, Dept Rheumatol, Adelaide, SA, Australia
[5] Univ Adelaide, Dept Med, Adelaide, SA, Australia
[6] Queen Elizabeth Hosp, Adelaide, SA, Australia
[7] Univ Adelaide, Adelaide, SA, Australia
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
448
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Tapering conventional synthetic DMARDs towards sustained drug-free remission in rheumatoid arthritis
    van Mulligen, Elise
    LANCET RHEUMATOLOGY, 2024, 6 (05): : e254 - e255
  • [2] Early Remission at 6 Months as a Predictor of Longterm Remission in New Onset Rheumatoid Arthritis
    Sapart, Emilie
    Sokolova, Tatiana
    Avramovska, Aleksandra
    Sidiras, Paschalis
    Kleimberg, Sandra
    Dierckx, Stephanie
    de Bellefon, Laurent Meric
    Ribbens, Clio
    Malaise, Michel
    Di Romana, Silvana
    Badot, Valerie
    Durez, Patrick
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1644 - 1646
  • [3] EARLY REMISSION AT 6 MONTHS AS A PREDICTOR OF LONGTERM REMISSION IN NEW ONSET RHEUMATOID ARTHRITIS
    Emilie, S.
    Sokolova, T.
    Avramovska, A.
    Sidiras, P.
    Kleimberg, S.
    Dierckx, S.
    De Bellefon, L. Meric
    Ribbens, C.
    Malaise, M.
    Silvana, D. R.
    Badot, V.
    Durez, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1214 - 1214
  • [4] FREQUENCY AND PREDICTORS OF SUSTAINED REMISSION IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS TREATED WITH CONVENTIONAL SYNTHETIC DISEASE MODIFYING DRUGS
    Zanframundo, G.
    Bugatti, S.
    Manzo, A.
    Benaglio, F.
    Sakellariou, G.
    Montecucco, C.
    Caporali, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 277 - 278
  • [5] ADVERSE EVENTS RELATED TO CONVENTIONAL SYNTHETIC DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Rojas-Zuleta, Wilmer
    Becerra-Arias, Carolina
    Donado, Jorge
    Duque-Zapata, Natalia
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2023, 29 : S80 - S81
  • [6] Sustained clinical remission in rheumatoid arthritis: prevalence and prognostic factors in an inception cohort of patients treated with conventional DMARDS
    Jayakumar, Keeranur
    Norton, Sam
    Dixey, Josh
    James, David
    Gough, Andrew
    Williams, Peter
    Prouse, Peter
    Young, Adam
    RHEUMATOLOGY, 2012, 51 (01) : 169 - 175
  • [7] Cancers and cardiovascular diseases in patients with seropositive rheumatoid arthritis treated with JAK inhibitors, biologics, and conventional synthetic DMARDs
    Ahn, S. S.
    Han, M.
    Jung, I.
    Kim, H. W.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (09) : 1908 - 1916
  • [8] Remission in Early Rheumatoid Arthritis: Predicting Treatment Response
    Ma, Margaret H. Y.
    Ibrahim, Fowzia
    Walker, David
    Hassell, Andrew
    Choy, Ernest H.
    Kiely, Patrick D. W.
    Williams, Richard
    Walsh, David A.
    Young, Adam
    Scott, David L.
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (03) : 470 - 475
  • [9] Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort
    Cédric Lukas
    Julia Mary
    Michel Debandt
    Claire Daïen
    Jacques Morel
    Alain Cantagrel
    Bruno Fautrel
    Bernard Combe
    Arthritis Research & Therapy, 21
  • [10] Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort
    Lukas, Cedric
    Mary, Julia
    Debandt, Michel
    Daien, Claire
    Morel, Jacques
    Cantagrel, Alain
    Fautrel, Bruno
    Combe, Bernard
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (01)
12345